HK Stock Market Move | Conch Group actively increased its holdings in its subsidiary companies, with Conch Venture (00586) rising by over 8% and Anhui Conch Cement (00914) rising by over 6%.
Top securities in the morning, as of press time, Conch Group (00586) rose 7.66% to HKD 13.5; Conch Cement (00914) rose 5.77% to HKD 26.76.
Conch Venture rose in the early morning, as of the time of writing, CONCH VENTURE (00586) increased by 7.66% to HK$13.5; Anhui Conch Cement (00914) rose by 5.77% to HK$26.76.
On the news front, on February 24, Anhui Conch Cement announced that the controlling shareholder, Conch Group, plans to increase its holdings of the company's A shares within six months from the date of announcement. The amount of the increase shall not be less than RMB 700 million and not more than RMB 1.4 billion. The price range is not set for this increase. As of the announcement date, Conch Group holds 1.929 billion A shares of the company, accounting for 36.4% of the total share capital.
It is worth noting that the Shanghai Supervision and Administration Bureau announced that Conch Group intends to increase its shareholding in CONCH VENTURE by approximately 10.61% through cash increase in the secondary stock market. Soochow stated that CONCH VENTURE has a market value of HK$23.4 billion, a P/B ratio of 0.44 times, and an estimated profit of HK$900 million in 2026. Based on a P/E ratio of 9 times given by peers, the valuation is HK$8.1 billion, corresponding to a cement equity valuation of HK$15.3 billion. This is a 64% discount compared to the HK$238 billion valuation of Anhui Conch Cement's Hong Kong stock market value of HK$1.336 billion.
Related Articles

Pfizer Inc.'s oral anticancer drug Braftovi gets FDA approval for treating colorectal cancer.

HK Stock Market Move | Lithium carbonate futures once broke through the 170,000 mark. Tianqi Lithium Corporation (09696) rose more than 4%, and Ganfeng Lithium Group (01772) rose more than 3%.

HK Stock Market Move | JIAXIN INTL RES(03858) rises by 8%, tungsten prices continue to rise, and the company is included in the Hang Seng Composite Index.
Pfizer Inc.'s oral anticancer drug Braftovi gets FDA approval for treating colorectal cancer.

HK Stock Market Move | Lithium carbonate futures once broke through the 170,000 mark. Tianqi Lithium Corporation (09696) rose more than 4%, and Ganfeng Lithium Group (01772) rose more than 3%.

HK Stock Market Move | JIAXIN INTL RES(03858) rises by 8%, tungsten prices continue to rise, and the company is included in the Hang Seng Composite Index.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


